CME

CME


Latest Episodes

Evolving Management Strategies for BRAF-Mutant Metastatic Colorectal Cancer
November 03, 2021

Host: Scott Kopetz, MD, PhD Guest: Rona Yaeger, MD Advances in the diagnosis and treatment of mCRC enable personalized care based on the molecular profile of the tumor to achieve improved outcomes. About 5% to 15% of mCRC patients have a mutation i

Keeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
October 29, 2021

Host: Johann de Bono, MD, PhD Guest: Alicia K. Morgans, MD, MPH Prostate cancer is the second most common cancer in incidence and the fifth most frequent cause of cancer-related mortality in men worldwide. With the broader availability of PSA scree

Emerging Treatment Strategies for the Management of Patients with Chronic Cough - Cases
October 29, 2021

Guest: Garth W. Garrison, MD The diagnosis and management of chronic cough can be challenging. Only an estimated 50% of patients with chronic cough are accurately diagnosed. Recent advances in the understanding and management of refractory chronic co

Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
October 26, 2021

Host: Mikhail Kosiborod, MD Guest: Ewa A. Jankowska, MD, PhD, FESC Guest: Phil McEwan, PhD Assessing iron deficiency is a crucial aspect of heart failure (HF) that warrants close clinical consideration, especially because it remains underdiagnose

The Itch Clinic: Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients – Real-World Cases
October 20, 2021

Guest: Steven Fishbane, MD Guest: Shayan Shirazian, MD Host: Jennifer Caudle, DO At least 25% of patients with chronic kidney disease (CKD), and between 50% to 86% of patients with CKD on dialysis suffer from CKD-associated pruritus (CKD-aP). The

From Guidelines to Practice: Key Updates From 2021 HFSA
October 15, 2021

Host: Ileana L. Piña, MD, MPH, FAHA, FACC Guest: Javed Butler, MD, MBA, MPH Guest: Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA Rapid initiation and up-titration of guideline-directed medical therapy (GDMT) is critical to achieve optimal patient out

Clinicians' Update on Omega-3s in ASCVD Risk Reduction
October 14, 2021

Host: Robert J. Chilton, DO Guest: John R. Nelson, MD, FACC, FNLA, FASNC Join Drs. Chilton and Nelson as they discuss recent omega-3 fatty acid (OM-3) outcomes trial results and how to apply those results along with evidence-based guidelines to re

Narcolepsy: Awakening to a New Day in Its Management
September 30, 2021

Host: Louis Kuritzky, MD Guest: Karl Doghramji, MD, FAASM, DFAPA Guest: Julie Flygare, JD Guest: Phyllis C. Zee, MD, PhD Excessive sleepiness is a common, highly impactful problem not commonly reported and frequently misdiagnosed by physicians.

Hot Topics in HCV: A Multidisciplinary Online Minicurriculum - Activity 2: The Dual Realities of the Opioid Epidemic and Rising Maternal HCV Rates: What the OB/GYN Needs to Know!
September 29, 2021

Host: Ricardo Franco, MD Guest: Catherine A. Chappell, MD MSc With alarming increases in the incidence of maternal HCV, your obstetrics and gynecology (OB/GYN) practice plays a critical role in screening of all pregnant patients and engaging HCV-in

Hot Topics in HCV: A Multidisciplinary Online Minicurriculum - Activity 3: Anticipating the Impact of the COVID-19 Pandemic on Vulnerable Populations
September 29, 2021

Host: Ricardo Franco, MD Guest: David L. Wyles, MD The COVID-19 pandemic has taken a disproportional toll on already vulnerable persons, yet substance use, psychosocial comorbidities, and preexisting disparities in access to care may translate to a